Navigation Links
CorMatrix Receives Carotid Artery Repair Indication for its CorMatrix® ECM®
Date:10/12/2011

uires from the clinical surgery community for a CorMatrix product to address this clinical need, we were very pleased with the timely manner in which FDA reviewed and cleared this submission." stated David Camp, Chairman & CEO of CorMatrix.

About Extracellular Matrix Biomaterial

The unique properties of extracellular matrix biomaterials were discovered at Purdue University. The decellularized matrix material serves as a scaffold to allow adjacent tissues to deliver cells and nutrients to the matrix, which then differentiate into tissue-specific cells. The CorMatrix implant is gradually replaced, as the patient's own body reinforces and rebuilds the weakened site. During the repair, the matrix is naturally degraded and resorbed, leaving remodeled functional tissue where scar tissue or injured tissue would normally be expected.

The use of extracellular matrix materials in non-cardiovascular applications has established a significant foothold in soft tissue repair, wound management and orthopedic applications. The safety of extracellular matrices has been well established in a number of different clinical applications. The extracellular matrix has been studied extensively, with more than 500 published papers. Since 1999, over a million patients worldwide have received an extracellular matrix implant.

About CorMatrix ECM Technology

CorMatrix Cardiovascular holds an exclusive license from Purdue University to research, develop, manufacture and market naturally occurring ECM products for cardiovascular applications. The company currently has U.S. clearance and European approval with a CE Mark for its ECM Technology as an implant for pericardial closure and for use in cardiac tissue repair.

About CorMatrix Cardiovascular, Inc.

CorMatrix Cardiovascular, a privately held company based in Atlanta, Georgia, is dedicated to developing and delivering innovative cardiovascular devices that harness the body'
'/>"/>

SOURCE CorMatrix Cardiovascular, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
2. CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
3. CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
4. Ventana Medical Systems, Inc. Receives First FDA 510(k) Clearance for H. pylori Antibody
5. Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology
6. JCM Receives the Approval for its Manufacturing Environmental Assessment
7. OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
8. University of Houston receives NSF grant for high school teachers program
9. GeNO LLC Receives Federal Grant To Advance Studies of Inhaled Nitric Oxide Product for the Treatment of Chronic Pulmonary Diseases
10. Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy
11. KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 ... an Irys™System by BGI , the ... enable comprehensive exploration of human structural variation (SV) and ... interest, including those where no reference exists. In addition, ... methods for multiplexing on the Irys System, enabling significantly ...
(Date:7/31/2014)... 31, 2014 The global market for ... by 2020, according to a new study by Grand ... theranostics, and the subsequent introduction of advanced cancer diagnostic ... growth over the next six years. Moreover, the growing ... as cancer, coupled with disease triggering lifestyle habits such ...
(Date:7/31/2014)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and ... products for cells and tissues, today announced today ... be released on Thursday, August 7, 2014, and that ... webcast at 4:30 p.m. ET that afternoon. Management will ...
(Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, LLC ( ... cell biotechnologies. Currently the company holds seven recently ... applications currently under examination by the U.S. Patent and ... the most vexing problems in adult stem cell biology ... difficult to identify; and they have been difficult to ...
Breaking Biology Technology:BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3
... Appointed -, CLINTON, N.J., Oct. 2 ... Kennedy as Senior Vice President,Engineering and Operations. In ... strategy and development., "Michael,s extensive experience will ... we continue to advance our pharmaceutical,pipeline through a ...
... DENVER, Oct. 2 Matthew B. Wiener, PharmD, ... the Outstanding,Cancer Leadership Award from the Colorado Cancer ... for his development of the Just-In-Time (JIT),enrollment methodology ... award on the evening of October 6th, at ...
... Epiphany Biosciences,Inc. announced today that Dr. Charles Sanders ... is a highly experienced biotechnology and,pharmaceutical executive, currently ... served as chief executive officer of Glaxo Inc., ... In addition, Dr. Sanders is also,a member of ...
Cached Biology Technology:Ikaria Strengthens Executive Leadership Team 2Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition 2
(Date:7/31/2014)... natural-gas production from shale rock has increased by ... still do not fully understand the industry,s effects ... in the journal Frontiers in Ecology and ... to vastly outpace scientific examination, a team of ... including Princeton University, concluded that determining the environmental ...
(Date:7/31/2014)... 3,000 genes to the earliest common ancestor of ... created an extensive "Tree of Lepidoptera" in the ... , Among the study,s more surprising findings: ... than to large ones, which completely changes scientists, ... found that some insects once classified as moths ...
(Date:7/31/2014)... shows the sustained efficacy, immunogenicity and safety ... Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted ... years, and vaccine efficacy (VE) against incident ... follow-up report for a licensed HPV vaccine. ... paper. , HPV and vaccination , ...
Breaking Biology News(10 mins):'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3UF study advances 'DNA revolution,' tells butterflies' evolutionary history 2UF study advances 'DNA revolution,' tells butterflies' evolutionary history 3Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... in Central Illinois are being exposed to polychlorinated biphenyls (PCBs) ... 1970s and ,80s. Their analysis appears in ... Illinois Department of Natural Resources collected 23 river otters between ... by cars or accidentally caught in traps, for example). The ...
... and other amphibians around the world releases a toxic ... investigators report Oct. 18 in the journal Science ... a long-standing puzzle why the amphibian immune system ... said Louise Rollins-Smith, Ph.D., associate professor of Pathology, Microbiology ...
... Oct. 10, 2013   DigitalPersona, Inc. , a ... announced the acquisition of Identity Stream, a leading ... identification of customers and employees in financial institutions.  ... Temenos, the banking software company, as T24 Biometrics.  ...
Cached Biology News:Illinois river otters exposed to chemicals banned decades ago 2Illinois river otters exposed to chemicals banned decades ago 3Frog-killing fungus paralyzes amphibian immune response 2DigitalPersona Expands Secure Banking Solutions Portfolio with Software Acquisition 2DigitalPersona Expands Secure Banking Solutions Portfolio with Software Acquisition 3
... The Yeast Whole Genome ChIP-on-chip Microarray ... of yeast (S. cerevisiae) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
... Salmonella genomes has allowed the development of ... pairs. The S. enterica Typhimurium (strain LT2) ... bp; 4,440 ORFs) and a plasmid, pSLT ... Sigma-Genosys have been designed to amplify all ...
... your lab productivity and allows you to achieve ... Move ahead beyond traditional paper-based weighing processes into ... *Instruments supported: ... XS, XP, PR, SR, PG-S, PG, SG, AT, ...
... ,Components g/500 ml: ,Tryptone ... chloride 2.5 ,Agar 6.0 ,S-Gal ... ,IPTG 0.025 ,Kanamycin 0.0175 ... complete growth medium containing S-Gal ...
Biology Products: